ResearcherKyushu UniversityActive in the last 2 years
So Nakamura
Matched on ORCID iD 0000-0002-3699-2449; OpenAlex author ID A5007492743. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 29
2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 4 papers · 2024: 1 paper
Papers 7
- MicroRNA-20a in extracellular vesicles derived from duodenal fluid is a possible biomarker for pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/deo2.333↗
- Minimally invasive distal pancreatectomy for pancreatic cancer: cranial-to-caudal approach with identification of Gerota's fascia (with video). Co-author DOI 10.1007/s00464-023-10438-7↗
- Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. Co-author DOI 10.1007/s11605-023-05591-2↗
- Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Resection. Co-author DOI 10.1245/s10434-023-13936-z↗
- Preoperative frailty as a predictive factor for postoperative complications in patients with pancreatic cancer. Co-author DOI 10.18999/nagjms.85.3.518↗
- Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-019-07269-z↗
- Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special reference to the incidence of concomitant pa… Co-author DOI 10.1016/j.surg.2017.09.040↗
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kohei Nakata · 5 shared papers, 2019–2024 · strength 0.77
- Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
- Paper Minimally invasive distal pancreatectomy for pancreatic cancer: cranial-to-caudal approach with identification of Gerot… DOI 10.1007/s00464-023-10438-7↗
- Paper MicroRNA-20a in extracellular vesicles derived from duodenal fluid is a possible biomarker for pancreatic ductal adenoc… DOI 10.1002/deo2.333↗
- Toshiya Abe · 4 shared papers, 2023–2024 · strength 0.69
- Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
- Paper Minimally invasive distal pancreatectomy for pancreatic cancer: cranial-to-caudal approach with identification of Gerot… DOI 10.1007/s00464-023-10438-7↗
- Paper MicroRNA-20a in extracellular vesicles derived from duodenal fluid is a possible biomarker for pancreatic ductal adenoc… DOI 10.1002/deo2.333↗
- Noboru Ideno · 4 shared papers, 2023–2024 · strength 0.69
- Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
- Paper Minimally invasive distal pancreatectomy for pancreatic cancer: cranial-to-caudal approach with identification of Gerot… DOI 10.1007/s00464-023-10438-7↗
- Paper MicroRNA-20a in extracellular vesicles derived from duodenal fluid is a possible biomarker for pancreatic ductal adenoc… DOI 10.1002/deo2.333↗
- Naoki Ikenaga · 4 shared papers, 2023–2024 · strength 0.69
- Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
- Paper Minimally invasive distal pancreatectomy for pancreatic cancer: cranial-to-caudal approach with identification of Gerot… DOI 10.1007/s00464-023-10438-7↗
- Paper MicroRNA-20a in extracellular vesicles derived from duodenal fluid is a possible biomarker for pancreatic ductal adenoc… DOI 10.1002/deo2.333↗
- Yoshinao Oda · 4 shared papers, 2018–2024 · strength 0.50
- Paper MicroRNA-20a in extracellular vesicles derived from duodenal fluid is a possible biomarker for pancreatic ductal adenoc… DOI 10.1002/deo2.333↗
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Paper Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special refe… DOI 10.1016/j.surg.2017.09.040↗
- Masafumi Nakamura · 3 shared papers, 2019–2024 · strength 0.44
- Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
- Paper MicroRNA-20a in extracellular vesicles derived from duodenal fluid is a possible biomarker for pancreatic ductal adenoc… DOI 10.1002/deo2.333↗
- Paper Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-019-07269-z↗
- Masafumi Nakamura · 3 shared papers, 2018–2023 · strength 0.42
- Paper Minimally invasive distal pancreatectomy for pancreatic cancer: cranial-to-caudal approach with identification of Gerot… DOI 10.1007/s00464-023-10438-7↗
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Paper Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special refe… DOI 10.1016/j.surg.2017.09.040↗
- Kazuyoshi Nishihara · 2 shared papers, 2023 · strength 0.36
- Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
- Paper Preoperative frailty as a predictive factor for postoperative complications in patients with pancreatic cancer. DOI 10.18999/nagjms.85.3.518↗
- Kenoki Ohuchida · 2 shared papers, 2023–2024 · strength 0.35
- Paper Minimally invasive distal pancreatectomy for pancreatic cancer: cranial-to-caudal approach with identification of Gerot… DOI 10.1007/s00464-023-10438-7↗
- Paper MicroRNA-20a in extracellular vesicles derived from duodenal fluid is a possible biomarker for pancreatic ductal adenoc… DOI 10.1002/deo2.333↗
- Kousei Ishigami · 2 shared papers, 2023 · strength 0.34
- Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Nobuhiro Fujita · 2 shared papers, 2023 · strength 0.34
- Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Takao Ohtsuka · 3 shared papers, 2018–2024 · strength 0.34
- Paper MicroRNA-20a in extracellular vesicles derived from duodenal fluid is a possible biomarker for pancreatic ductal adenoc… DOI 10.1002/deo2.333↗
- Paper Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special refe… DOI 10.1016/j.surg.2017.09.040↗
- Paper Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-019-07269-z↗
- Kenjiro Date · 2 shared papers, 2018–2023 · strength 0.26
- Paper Preoperative frailty as a predictive factor for postoperative complications in patients with pancreatic cancer. DOI 10.18999/nagjms.85.3.518↗
- Paper Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special refe… DOI 10.1016/j.surg.2017.09.040↗
- Makoto Onji · 1 shared paper, 2023 · strength 0.18
- Koichi Naito · 1 shared paper, 2023 · strength 0.18
- Yusuke Mizuuchi · 1 shared paper, 2023 · strength 0.18
- Masafumi Nakamura · 1 shared paper, 2023 · strength 0.18
- Masahiro Yamamoto · 1 shared paper, 2024 · strength 0.17
- Koji Tamura · 1 shared paper, 2024 · strength 0.17
- Takashi Taniguchi · 1 shared paper, 2024 · strength 0.17
- Yasuhisa Mori · 2 shared papers, 2018–2019 · strength 0.17
- Yoshihiro Miyasaka · 2 shared papers, 2018–2019 · strength 0.17
- Masataka Hayashi · 1 shared paper, 2023 · strength 0.16
- Masatoshi Murakami · 1 shared paper, 2023 · strength 0.16
- Nao Fujimori · 1 shared paper, 2023 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.